Cargando…

Burden of Menstrual Pain Measured by Heatmap Visualization of Daily Patient-Reported Data in Japanese Patients Treated with Ethinylestradiol/Drospirenone: A Randomized Controlled Study

PURPOSE: Dysmenorrhea negatively affects women’s quality of life and poses a considerable economic burden. A recent study in Japanese patients with dysmenorrhea (NCT01892904) reported a significant reduction in the number of days with menstrual pain after treatment with a flexible extended regimen o...

Descripción completa

Detalles Bibliográficos
Autores principales: Momoeda, Mikio, Akiyama, Sayako, Yamamoto, Shigetomo, Kondo, Masami, Fukai, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071861/
https://www.ncbi.nlm.nih.gov/pubmed/32210639
http://dx.doi.org/10.2147/IJWH.S242864
_version_ 1783506295099228160
author Momoeda, Mikio
Akiyama, Sayako
Yamamoto, Shigetomo
Kondo, Masami
Fukai, Takeshi
author_facet Momoeda, Mikio
Akiyama, Sayako
Yamamoto, Shigetomo
Kondo, Masami
Fukai, Takeshi
author_sort Momoeda, Mikio
collection PubMed
description PURPOSE: Dysmenorrhea negatively affects women’s quality of life and poses a considerable economic burden. A recent study in Japanese patients with dysmenorrhea (NCT01892904) reported a significant reduction in the number of days with menstrual pain after treatment with a flexible extended regimen of ethinylestradiol (EE)/drospirenone (DRSP) compared with a cyclic regimen. However, individual patients’ menstrual pain patterns and intensities were not indicated. Heatmapping was used to visualize menstrual pain patterns and intensities by re-evaluating the previously published data from NCT01892904. PATIENTS AND METHODS: NCT01892904 was a Phase III, multicenter, randomized, open-label, active-control study of 212 women aged ≥20 years randomized 1:1 to receive flexible extended or 28-day cyclic EE/DRSP treatment. Daily pain levels were recorded in patient diaries, and menstrual pain patterns and intensities were visualized using heatmapping. Patients were stratified by baseline dysmenorrhea scores and primary or secondary dysmenorrhea. RESULTS: The heatmap data demonstrated that EE/DRSP reduced the degree of menstrual pain. Regular peaks of menstrual pain were alleviated in the extended regimen group but were still observed in the cyclic regimen group. While a decrease in the days with menstrual pain was observed in patients with higher baseline dysmenorrhea scores (5–6), those with lower baseline scores (3–4) were more likely to experience lower intensities of menstrual pain. Although pain relief was less likely in patients with secondary dysmenorrhea, those who had lower baseline dysmenorrhea scores (3–4) and received the flexible extended regimen experienced a greater reduction in the number of days with menstrual pain than those who received the cyclic regimen. CONCLUSION: Heatmapping effectively visualized the daily burden of menstrual pain in Japanese patients with dysmenorrhea. The analysis using heatmaps suggested that the flexible extended EE/DRSP treatment regimen was more likely to alleviate the regular occurrence of menstrual pain peaks compared with the cyclic regimen.
format Online
Article
Text
id pubmed-7071861
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-70718612020-03-24 Burden of Menstrual Pain Measured by Heatmap Visualization of Daily Patient-Reported Data in Japanese Patients Treated with Ethinylestradiol/Drospirenone: A Randomized Controlled Study Momoeda, Mikio Akiyama, Sayako Yamamoto, Shigetomo Kondo, Masami Fukai, Takeshi Int J Womens Health Original Research PURPOSE: Dysmenorrhea negatively affects women’s quality of life and poses a considerable economic burden. A recent study in Japanese patients with dysmenorrhea (NCT01892904) reported a significant reduction in the number of days with menstrual pain after treatment with a flexible extended regimen of ethinylestradiol (EE)/drospirenone (DRSP) compared with a cyclic regimen. However, individual patients’ menstrual pain patterns and intensities were not indicated. Heatmapping was used to visualize menstrual pain patterns and intensities by re-evaluating the previously published data from NCT01892904. PATIENTS AND METHODS: NCT01892904 was a Phase III, multicenter, randomized, open-label, active-control study of 212 women aged ≥20 years randomized 1:1 to receive flexible extended or 28-day cyclic EE/DRSP treatment. Daily pain levels were recorded in patient diaries, and menstrual pain patterns and intensities were visualized using heatmapping. Patients were stratified by baseline dysmenorrhea scores and primary or secondary dysmenorrhea. RESULTS: The heatmap data demonstrated that EE/DRSP reduced the degree of menstrual pain. Regular peaks of menstrual pain were alleviated in the extended regimen group but were still observed in the cyclic regimen group. While a decrease in the days with menstrual pain was observed in patients with higher baseline dysmenorrhea scores (5–6), those with lower baseline scores (3–4) were more likely to experience lower intensities of menstrual pain. Although pain relief was less likely in patients with secondary dysmenorrhea, those who had lower baseline dysmenorrhea scores (3–4) and received the flexible extended regimen experienced a greater reduction in the number of days with menstrual pain than those who received the cyclic regimen. CONCLUSION: Heatmapping effectively visualized the daily burden of menstrual pain in Japanese patients with dysmenorrhea. The analysis using heatmaps suggested that the flexible extended EE/DRSP treatment regimen was more likely to alleviate the regular occurrence of menstrual pain peaks compared with the cyclic regimen. Dove 2020-03-10 /pmc/articles/PMC7071861/ /pubmed/32210639 http://dx.doi.org/10.2147/IJWH.S242864 Text en © 2020 Momoeda et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Momoeda, Mikio
Akiyama, Sayako
Yamamoto, Shigetomo
Kondo, Masami
Fukai, Takeshi
Burden of Menstrual Pain Measured by Heatmap Visualization of Daily Patient-Reported Data in Japanese Patients Treated with Ethinylestradiol/Drospirenone: A Randomized Controlled Study
title Burden of Menstrual Pain Measured by Heatmap Visualization of Daily Patient-Reported Data in Japanese Patients Treated with Ethinylestradiol/Drospirenone: A Randomized Controlled Study
title_full Burden of Menstrual Pain Measured by Heatmap Visualization of Daily Patient-Reported Data in Japanese Patients Treated with Ethinylestradiol/Drospirenone: A Randomized Controlled Study
title_fullStr Burden of Menstrual Pain Measured by Heatmap Visualization of Daily Patient-Reported Data in Japanese Patients Treated with Ethinylestradiol/Drospirenone: A Randomized Controlled Study
title_full_unstemmed Burden of Menstrual Pain Measured by Heatmap Visualization of Daily Patient-Reported Data in Japanese Patients Treated with Ethinylestradiol/Drospirenone: A Randomized Controlled Study
title_short Burden of Menstrual Pain Measured by Heatmap Visualization of Daily Patient-Reported Data in Japanese Patients Treated with Ethinylestradiol/Drospirenone: A Randomized Controlled Study
title_sort burden of menstrual pain measured by heatmap visualization of daily patient-reported data in japanese patients treated with ethinylestradiol/drospirenone: a randomized controlled study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071861/
https://www.ncbi.nlm.nih.gov/pubmed/32210639
http://dx.doi.org/10.2147/IJWH.S242864
work_keys_str_mv AT momoedamikio burdenofmenstrualpainmeasuredbyheatmapvisualizationofdailypatientreporteddatainjapanesepatientstreatedwithethinylestradioldrospirenonearandomizedcontrolledstudy
AT akiyamasayako burdenofmenstrualpainmeasuredbyheatmapvisualizationofdailypatientreporteddatainjapanesepatientstreatedwithethinylestradioldrospirenonearandomizedcontrolledstudy
AT yamamotoshigetomo burdenofmenstrualpainmeasuredbyheatmapvisualizationofdailypatientreporteddatainjapanesepatientstreatedwithethinylestradioldrospirenonearandomizedcontrolledstudy
AT kondomasami burdenofmenstrualpainmeasuredbyheatmapvisualizationofdailypatientreporteddatainjapanesepatientstreatedwithethinylestradioldrospirenonearandomizedcontrolledstudy
AT fukaitakeshi burdenofmenstrualpainmeasuredbyheatmapvisualizationofdailypatientreporteddatainjapanesepatientstreatedwithethinylestradioldrospirenonearandomizedcontrolledstudy